title: Percutaneous transluminal angioplasty for chronic cerebrospinal venous insufficiency in multiple sclerosis: dichotomy between subjective and objective outcome scores.
abstract: Some multiple sclerosis (MS) patients reported an improvement after percutaneous transluminal angioplasty (PTA) for chronic cerebrospinal venous insufficiency (CCSVI), despite the lack of correspondence with objective outcome scores. The objective was to assess neurologic and quality of life scores before and after PTA for CCSVI in an observational study after a self-decided approach. 44 consecutive MS patients (21/23 M/F; median age 43 years, SD 9.8) who underwent PTA were evaluated before endovascular treatment for CCSVI and after 12 months. Neurologic outcome was assessed with EDSS, the annualized relapse rate (ARR) and frequency of new lesions at MRI after PTA. Quality of life was evaluated through the MSQoL-54 questionnaire. No modification in the ARR (p = 0.829), worsening of disability status (p = 0.002) and new lesions at MRI in 29.6 % of patients were found, in contrast to an improvement both in physical and mental domains of MSQoL-54 (p = 0.003). Multiple logistic regression showed EDSS score before PTA to be predictor of an increase of >10 points in MSQoL-54 mental domain (OR 0.52, 95 % CI, 0.31-0.89, p = 0.018). Spontaneously performed approach to CCSVI does not improve clinical and MRI parameters, despite frequent subjective perception of quality of life improvement.
authors: Clinic of Neurology, Department of Experimental and Clinical Medicine, Polytechnic University of Marche, Via Conca 71, 60100, Ancona, Italy.
authors: Sara
authors: S
authors: Zagaglia
authors: Simona
authors: S
authors: Balestrini
authors: Eva
authors: E
authors: Perticaroli
authors: Maura C
authors: MC
authors: Danni
authors: Simona
authors: S
authors: Luzzi
authors: Mauro
authors: M
authors: Silvestrini
authors: Leandro
authors: L
authors: Provinciali
mesh_terms: D000328:Adult; D017130:Angioplasty; D001921:Brain / Q000098:blood supply*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000150:complications / Q000523:psychology* / Q000628:therapy*; D011788:Quality of Life; D013116:Spinal Cord / Q000098:blood supply*; D016896:Treatment Outcome; D014689:Venous Insufficiency / Q000150:complications / Q000523:psychology* / Q000628:therapy*
references: J R Soc Med. 2006 Nov;99(11):589-93
references: 17082306
references: Neurol Sci. 2013 Sep;34(9):1633-7
references: 23354606
references: Neuro Endocrinol Lett. 2011;32(4):557-62
references: 21876515
references: Neurology. 1983 Nov;33(11):1444-52
references: 6685237
references: Health Qual Life Outcomes. 2010 Jun 07;8:55
references: 20529265
references: Eur J Vasc Endovasc Surg. 2012 Jan;43(1):116-22
references: 21839654
references: J Vasc Interv Radiol. 2012 Jan;23(1):55-9
references: 22088659
references: Funct Neurol. 2012 Jan-Mar;27(1):55-9
references: 22687168
references: Mult Scler. 2013 Jun;19(7):961-3
references: 23380649
references: Phlebology. 2012 Mar;27 Suppl 1:187-9
references: 22312088
references: Philos Trans R Soc Lond B Biol Sci. 2011 Jun 27;366(1572):1828-37
references: 21576140
references: Can J Neurol Sci. 2011 Sep;38(5):741-6
references: 21856578
references: Phlebology. 2011 Sep;26(6):254-6
references: 21803799
references: Lancet. 2010 Feb 20;375(9715):686-95
references: 20171404
references: J Neurol Neurosurg Psychiatry. 1999 Aug;67(2):158-62
references: 10406981
references: Can J Neurol Sci. 2013 Mar;40(2):210-8
references: 23419570
references: Phlebology. 2010 Dec;25(6):269-79
references: 21106999
references: Mult Scler. 2003 Feb;9(1):1-5
references: 12617260